 Each enzyme subunit from the homotetramer has two binding sites for these inhibitors.The allosteric (A) site overlaps with the site for the ribose-5-phosphate of PRPP, while the catalytic (C) site overlaps with the site for the pyrophosphate of PRPP.The binding of specific nucleotide pairs to the two sites results in synergistic inhibition stronger than additive inhibition.